Positive Support Services in North Yorkshire and York
NYAA provides support for people in North Yorkshire and York who are living with or affected by HIV. From 1st July 2015, our support services will be delivered as part of our Partnership with York Teaching Hospital NHS under the recognised name YorSexualHealth.
On this website, you can find more information about who we are in the “About NYAA” section and what we do – what services we can provide – in the “Services” section. There is also an overview of information about HIV and HIV treatment in the “Information About HIV” section, with suggestions on where to find reliable, more detailed information. And there is also a “News” section, for news not only about NYAA, but also about things to do with HIV that might be of interest.
You can find our contact details here.
Topics on this page include the following: you can jump to them by clicking on the headings below:
Two-drug Regimen Maintains Viral Suppression
Normal treatment for HIV involves taking three drug – so-called “triple therapy”, HAART, or cART. Whilst this is good for keeping the virus suppressed – so that the viral load is undetectable – taking three drugs can sometimes lead to side-effects. So work is being done to see if the drug burden can be reduced – so-called “treatment simplification”.
A two-drug regimen of dolutegravir and rilpivirine was able to maintain undetectable viral load for up to 48 weeks in people switching from standard HIV treatment. These are encouraging early results from a phase 3 clinical trial of a treatment simplification strategy. Final results will only be reported 148 weeks after switching. Read more here.
The Search for a Cure
A therapeutic vaccine has for the first time given exciting results in humans. Thirteen people took the HIV Conserv vaccine, a drug called romidepsin, and then stopped taking their conventional HIV treatment. While viral load quickly increased in eight people, the other five people have controlled HIV at very low levels for up to 28 weeks. This has been seen in monkeys before but never in humans. Read more here.